Abstract

Medical nutrition therapy (MNT) is a necessary component of comprehensive type 2 diabetes (T2D) management, but optimal outcomes require culturally-sensitive implementation. Accordingly, international experts created an evidence-based transcultural diabetes nutrition algorithm (tDNA) to improve understanding of MNT and to foster portability of current guidelines to various dysglycemic populations worldwide. This report details the development of tDNA-Venezuelan via analysis of region-specific cardiovascular disease (CVD) risk factors, lifestyles, anthropometrics, and resultant tDNA algorithmic modifications. Specific recommendations include: screening for prediabetes (for biochemical monitoring and lifestyle counseling); detecting obesity using Latin American cutoffs for waist circumference and Venezuelan cutoffs for BMI; prescribing MNT to people with prediabetes, T2D, or high CVD risk; specifying control goals in prediabetes and T2D; and describing regional differences in prevalence of CVD risk and lifestyle. Venezuelan deliberations involved evaluating typical food-based eating patterns, correcting improper dietary habits through adaptation of the Mediterranean diet with local foods, developing local recommendations for physical activity, avoiding stigmatizing obesity as a cosmetic problem, avoiding misuse of insulin and metformin, circumscribing bariatric surgery to appropriate indications, and using integrated health service networks to implement tDNA. Finally, further research, national surveys, and validation protocols focusing on CVD risk reduction in Venezuelan populations are necessary.

Highlights

  • At present, 346 million people worldwide have diabetes mellitus

  • In 140 subjects with mean age of 48 years, with body mass index (BMI) of 32.1 kg/m2, and who were randomly assigned to an intensive lifestyle (ILS, n = 70) intervention group or standard intervention control (n = 70) group for two years, significant improvements from baseline were observed in weight, waist circumference, diastolic blood pressure, triglycerides, HDL-cholesterol, fasting blood glucose, and cardiovascular health scores, ILS group vs. control [97]

  • Prevention and appropriate treatment of prediabetes, type 2 diabetes (T2D), and related or associated cardiovascular risk factors must be based on lifestyle changes that include an increase in physical activity and the correct implementation of Medical nutrition therapy (MNT)

Read more

Summary

Introduction

346 million people worldwide have diabetes mellitus. It has been estimated that the prevalence of type 2 diabetes mellitus (T2D) will increase more in Latin America (65%) than worldwide (54%) between 2010 and 2030 [1]. There are salient differences in lifestyle and dietary habits, patterns of physical activity, food availability, medical resources, and clinical practices within the country. These issues must be considered prior to any innovative process to improve diabetes care, such as the proposed Latin America Diabetes Association (ALAD) CPG that convey culturally-adapted recommendations from various international diabetes organizations [8]. The present report represents the current stage of tDNA adaptation in Venezuela, whereby a specific culture and locale will create its own version based on epidemiological, physiological, nutritional, and pathological parameters, as well as body composition and lifestyle. We describe the Venezuelan tDNA application (Figure 1) and prepare it for eventual validation protocols

Transcultural Factors for Venezuela
Non-Communicable Diseases in Latin America and Venezuela
Healthcare System in Venezuela
Cardio-Metabolic Comorbidities and Related Risk Factors
Physical Activity in Venezuela
Current Local CPG and Proposed Recommendations
Diabetes-Specific Formulas to Facilitate Metabolic Control
Physical Activity Recommendations
Bariatric Surgery Indications
10 Muscle
Follow-Up Evaluation
Factors Affecting TDNA Implementation
Misconception of Obesity as an Esthetic Problem
Misconceptions Surrounding Insulin
Misuse of Metformin and Other Drugs in the Treatment of Obesity
More than recommended portions
Conclusions
Findings
Disclosures
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.